Ketamine to Treat Patients With Post-comatose Disorders of Consciousness

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The investigators will run a Randomized Clinical Trial with 30 patients with disorders of consciousness (DoC), with intravenous subanesthetic doses of ketamine. Patients will simultaneously undergo TMS-EEG. The piloting will be done on 3 patients, with EEG only.
Epistemonikos ID: 470aba5192aa7c18d6b5b003b89d2a46bd3f67cf
First added on: May 13, 2024